{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T08:41:01Z","timestamp":1758703261602,"version":"3.40.4"},"reference-count":99,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007446","name":"King Khalid University","doi-asserted-by":"publisher","award":["RGP2\/8\/45"],"award-info":[{"award-number":["RGP2\/8\/45"]}],"id":[{"id":"10.13039\/501100007446","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.cpcardiol.2025.103040","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T17:15:54Z","timestamp":1743268554000},"page":"103040","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Multidimensional Approach to Understanding Genetic Diversity, Risk Stratification, and Personalized Interventions in Pediatric Hypertrophic Cardiomyopathy"],"prefix":"10.1016","volume":"50","author":[{"given":"Mona","family":"Alromaihi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faris","family":"Alrumaihi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanian M.","family":"Alwanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajed Obaid","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nouf Nasser","family":"AlDuayji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somayah Mohammad","family":"Alfifi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amin A.","family":"Al-Doaiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahad M","family":"Alshabrmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Thornbury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahid Ullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2025.103040_bib0001","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1440-1681.2006.04340.x","article-title":"Genes, calcium and modifying factors in hypertrophic cardiomyopathy","volume":"33","author":"Tsoutsman","year":"2006","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0002","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0140-6736(99)06187-5","article-title":"Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy","volume":"355","author":"Marian","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0003","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/eurheartj\/ehv497","article-title":"European CardiomyopathyPilot Registry: eURObservational Research Programme of the European Society of Cardiology","volume":"37","author":"Elliott","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0004","series-title":"Proc. Natl. Acad. Sci. USA","first-page":"24691","article-title":"Distinct hypertrophic cardiomyopathy genotypes result in convergent sarcomeric proteoform profiles revealed by top-down proteomics","volume":"117","author":"Tucholski","year":"2020"},{"issue":"8","key":"10.1016\/j.cpcardiol.2025.103040_bib0005","doi-asserted-by":"crossref","DOI":"10.1111\/pai.13835","article-title":"Dermatophagoides pteronyssinus allergen Der p 22: Cloning, expression, IgE-binding in asthmatic children, and immunogenicity","volume":"33","author":"Zhou","year":"2022","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0006","doi-asserted-by":"crossref","first-page":"103016","DOI":"10.1016\/j.redox.2023.103016","article-title":"M2 macrophage exosome-derived lncRNA AK083884 protects mice from CVB3-induced viral myocarditis through regulating PKM2\/HIF-1\u03b1 axis mediated metabolic reprogramming of macrophages","volume":"69","author":"Zhang","year":"2024","journal-title":"Redox Biol"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0007","doi-asserted-by":"crossref","first-page":"158093","DOI":"10.1016\/j.cej.2024.158093","article-title":"Nanozyme-enhanced tyramine signal amplification probe for preamplification-free myocarditis-related miRNAs detection","volume":"503","author":"Li","year":"2025","journal-title":"Chem Eng J"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0008","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","article-title":"A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)","volume":"35","author":"O'Mahony","year":"2013","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.cpcardiol.2025.103040_bib98","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/jimaging8040102","article-title":"Novel hypertrophic cardiomyopathy diagnosis index using deep features and local directional pattern techniques","volume":"8","author":"Gudigar","year":"2022","journal-title":"J Imaging"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0009","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1530\/ERP-15-0007","article-title":"Diagnosis and management of hypertrophic cardiomyopathy","volume":"2","author":"Pantazis","year":"2015","journal-title":"EchoRes. Pract."},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0010","article-title":"Hypertrophic cardiomyopathy","volume":"27","author":"Antunes","year":"2020","journal-title":"IJC Heart Vasc"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0011","article-title":"Evaluation of subtle left ventricular systolic abnormalities in adult patients with hypertrophic cardiomyopathy","volume":"8","author":"Shetty","year":"2014","journal-title":"J.Clin. Diagn. Res."},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0012","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejmp.2019.05.004","article-title":"Computer-aided diagnosis of congestive heart failure using ECG signals\u2014A review","volume":"62","author":"Jahmunah","year":"2019","journal-title":"Phys. Medica"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0013","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1109\/RBME.2014.2319854","article-title":"Automated identification of infarcted myocardium tissue characterization using ultrasound images: a review","volume":"8","author":"Sudarshan","year":"2014","journal-title":"IEEE Rev Biomed Eng"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0014","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11886-020-01348-4","article-title":"Radiomics in echocardiography: deep learning and echocardiographic analysis","volume":"22","author":"Kusunose","year":"2020","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0015","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1007\/s00521-017-2839-5","article-title":"Automated screening of congestive heart failure using variational mode decomposition and texture features extracted from ultrasound images","volume":"28","author":"Raghavendra","year":"2017","journal-title":"Neural Comput Appl"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0016","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.bspc.2017.09.030","article-title":"Automated technique for coronary artery disease characterization and classification using DD-DTDWT in ultrasound images","volume":"40","author":"Raghavendra","year":"2018","journal-title":"Biomed. Signal Process. Control"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0017","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.patrec.2019.03.027","article-title":"Global weighted LBP based entropy features for the assessment of pulmonary hypertension","volume":"125","author":"Gudigar","year":"2019","journal-title":"Pattern Recognit. Lett."},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0018","doi-asserted-by":"crossref","first-page":"229043","DOI":"10.1109\/ACCESS.2020.3042594","article-title":"Local preserving class separation framework to identify gestational diabetes mellitus mother using ultrasound fetal cardiac image","volume":"8","author":"Gudigar","year":"2020","journal-title":"IEEE Access"},{"issue":"4","key":"10.1016\/j.cpcardiol.2025.103040_bib0019","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1021\/acsnano.3c05847","article-title":"Multitargeted Immunomodulatory Therapy for Viral Myocarditis by Engineered Extracellular Vesicles","volume":"18","author":"Pei","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0020","series-title":"Proceedings of the 2018 Fifth HCT Information Technology Trends (ITT), Dubai, United Arab Emirates","first-page":"41","article-title":"DPSO-FCM based segmentation and classification of DCM and HCM heart diseases","author":"Sharon","year":"2018"},{"issue":"6","key":"10.1016\/j.cpcardiol.2025.103040_bib99","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3390\/medicina55060299","article-title":"Exploring the continuum of hypertrophic cardiomyopathy\u2014From DNA to clinical expression","volume":"55","author":"Popa-Fotea","year":"2019","journal-title":"Medicina"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0021","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1161\/CIRCULATIONAHA.118.034338","article-title":"Fully automated echocardiogram interpretation in clinical practice:feasibility and diagnostic accuracy","volume":"138","author":"Zhang","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0022","doi-asserted-by":"crossref","first-page":"108","DOI":"10.21037\/atm-20-4891","article-title":"Artificial intelligence-based myocardial texture analysis in etiological differentiation of left ventricular hypertrophy","volume":"9","author":"Yu","year":"2021","journal-title":"Ann Transl Med"},{"issue":"37","key":"10.1016\/j.cpcardiol.2025.103040_bib0023","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC Guidelines for the management of cardiomyopathies: developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC)","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.cpcardiol.2025.103040_bib0024","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1161\/CIR.0000000000001151","article-title":"Treatment strategies for cardiomyopathy in children: a scientific statement from the American Heart Association","volume":"148","author":"Bogle","year":"2023","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.cpcardiol.2025.103040_bib0025","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.stem.2024.04.021","article-title":"Modified lentiviral globin gene therapy for pediatric \u03b20\/\u03b20 transfusion-dependent \u03b2-thalassemia: A single-center, single-arm pilot trial","volume":"31","author":"Li","year":"2024","journal-title":"Cell Stem Cell"},{"issue":"5","key":"10.1016\/j.cpcardiol.2025.103040_bib0026","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s12012-020-09576-4","article-title":"Involvement of ROS\/NLRP3 Inflammasome Signaling Pathway in Doxorubicin-Induced Cardiotoxicity","volume":"20","author":"Wei","year":"2020","journal-title":"Cardiovasc Toxicol"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0027","doi-asserted-by":"crossref","first-page":"8345","DOI":"10.2147\/IJN.S219670","article-title":"Micelles Loaded With Puerarin And Modified With Triphenylphosphonium Cation Possess Mitochondrial Targeting And Demonstrate Enhanced Protective Effect Against Isoprenaline-Induced H9c2 Cells Apoptosis","volume":"14","author":"Li","year":"2019","journal-title":"Int J Nanomedicine"},{"issue":"7","key":"10.1016\/j.cpcardiol.2025.103040_bib0028","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMra1710575","article-title":"Clinical course and management of hypertrophic cardiomyopathy","volume":"379","author":"Maron","year":"2018","journal-title":"New England J Med"},{"issue":"14","key":"10.1016\/j.cpcardiol.2025.103040_bib0029","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/eurheartj\/ehs150","article-title":"Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence","volume":"33","author":"Spoladore","year":"2012","journal-title":"Eur. Heart J."},{"issue":"12","key":"10.1016\/j.cpcardiol.2025.103040_bib0030","article-title":"Baseline characteristics of the VANISH cohort","volume":"12","author":"Axelsson","year":"2019","journal-title":"Circulation: Heart Failure"},{"issue":"10","key":"10.1016\/j.cpcardiol.2025.103040_bib0031","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1038\/s41591-021-01505-4","article-title":"Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial","volume":"27","author":"Ho","year":"2021","journal-title":"Nat Med"},{"issue":"6273","key":"10.1016\/j.cpcardiol.2025.103040_bib0032","first-page":"617","article-title":"A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice","volume":"351","author":"Green","year":"2016","journal-title":"Science (1979)"},{"issue":"10293","key":"10.1016\/j.cpcardiol.2025.103040_bib0033","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1016\/S0140-6736(21)00763-7","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"397","author":"Spertus","year":"2021","journal-title":"The Lancet"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0034","doi-asserted-by":"crossref","first-page":"173690","DOI":"10.1016\/j.ejphar.2020.173690","article-title":"Xanthohumol attenuates isoprenaline-induced cardiac hypertrophy and fibrosis through regulating PTEN\/AKT\/mTOR pathway","volume":"891","author":"Sun","year":"2021","journal-title":"Eur J Pharmacol"},{"issue":"10","key":"10.1016\/j.cpcardiol.2025.103040_bib0035","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/jamacardio.2023.3030","article-title":"Effect of mavacamten on Chinese patients with symptomatic obstructive hypertrophic cardiomyopathy: the EXPLORER-CN randomized clinical trial","volume":"8","author":"Tian","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0036","doi-asserted-by":"crossref","first-page":"110525","DOI":"10.1016\/j.biopha.2020.110525","article-title":"NF-\u03baB pathway activation during endothelial-to-mesenchymal transition in a rat model of doxorubicin-induced cardiotoxicity","volume":"130","author":"Xu","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"10.1016\/j.cpcardiol.2025.103040_bib0037","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/eurheartj\/ehy798","article-title":"Clinical presentation and survival of childhood hypertrophic cardiomyopathy: a retrospective study in United Kingdom","volume":"40","author":"Norrish","year":"2019","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.cpcardiol.2025.103040_bib0038","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1161\/CIRCULATIONAHA.106.621185","article-title":"Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry","volume":"115","author":"Colan","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0039","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejphar.2018.10.023","article-title":"Calcitonin gene-related peptide inhibits the cardiac fibroblasts senescence in cardiac fibrosis via up-regulating klotho expression","volume":"843","author":"Li","year":"2019","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.cpcardiol.2025.103040_bib0040","first-page":"630","article-title":"Long-term outcomes after medical and invasive treatment in patients with hypertrophic cardiomyopathy","volume":"2","author":"Vriesendorp","year":"2014","journal-title":"JACC: Heart Failure"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0041","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.2147\/DDDT.S282206","article-title":"Xanthohumol Inhibits TGF-\u03b21-Induced Cardiac Fibroblasts Activation via Mediating PTEN\/Akt\/mTOR Signaling Pathway","volume":"14","author":"Jiang","year":"2020","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"10.1016\/j.cpcardiol.2025.103040_bib0042","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.athoracsur.2012.08.011","article-title":"Outcome of septal myectomy for obstructive hypertrophic cardiomyopathy in children and young adults","volume":"95","author":"Altarabsheh","year":"2013","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"10.1016\/j.cpcardiol.2025.103040_bib0043","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1097\/JS9.0000000000000426","article-title":"Residual or recurrent obstruction after septal myectomy in young children and infants with hypertrophic cardiomyopathy: cohort study","volume":"109","author":"Dong","year":"2023","journal-title":"Int. J. Sur."},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103040_bib0044","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.athoracsur.2019.10.016","article-title":"Childhood hypertrophic obstructive cardiomyopathy and its relevant surgical outcome","volume":"110","author":"Zhu","year":"2020","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"10.1016\/j.cpcardiol.2025.103040_bib0045","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.jtcvs.2018.06.040","article-title":"Long-term results of the modified Konno procedure in high-risk children with obstructive hypertrophic cardiomyopathy","volume":"156","author":"Laredo","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6","key":"10.1016\/j.cpcardiol.2025.103040_bib0046","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/ejcts\/ezu313","article-title":"Surgery for biventricular obstruction in hypertrophic cardiomyopathy in children and young adults: technique and outcomes","volume":"47","author":"Quintana","year":"2015","journal-title":"European J. Cardio-Thoracic Surg."},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0047","first-page":"1","article-title":"Safety and efficacy of alcohol septal ablation in adolescents and young adults with hypertrophic obstructive cardiomyopathy","author":"Lawin","year":"2022","journal-title":"Clinical Res. Cardiol."},{"issue":"24","key":"10.1016\/j.cpcardiol.2025.103040_bib0048","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1016\/j.jacc.2011.09.020","article-title":"Percutaneous radiofrequency septal reduction for hypertrophic obstructive cardiomyopathy in children","volume":"58","author":"Sreeram","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.cpcardiol.2025.103040_bib0049","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1016\/j.jacc.2018.07.080","article-title":"Percutaneous intramyocardial septal radiofrequency ablation for hypertrophic obstructive cardiomyopathy","volume":"72","author":"Liu","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0050","doi-asserted-by":"crossref","first-page":"914347","DOI":"10.3389\/fphar.2022.914347","article-title":"Synergistic effect of VEGF and SDF-1\u03b1 in endothelial progenitor cells and vascular smooth muscle cells","volume":"13","author":"Yang","year":"2022","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.cpcardiol.2025.103040_bib0051","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/jamacardio.2022.0259","article-title":"Percutaneous intramyocardial septal radiofrequency ablation in patients with drug-refractory hypertrophic obstructive cardiomyopathy","volume":"7","author":"Zhou","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"20","key":"10.1016\/j.cpcardiol.2025.103040_bib0053","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1093\/eurheartj\/ehab148","article-title":"Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy","volume":"42","author":"Marston","year":"2021","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103040_bib0054","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/CIRCULATIONAHA.115.017633","article-title":"Hypertrophic cardiomyopathy in children, adolescents, and young adults associated with low cardiovascular mortality with contemporary management strategies","volume":"133","author":"Maron","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0055","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1016\/j.jacc.2011.06.011","article-title":"2011 ACCF\/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy","volume":"58","author":"Gersh","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0056","doi-asserted-by":"crossref","first-page":"116337","DOI":"10.1016\/j.biopha.2024.116337","article-title":"The Janus face of mitophagy in myocardial ischemia\/reperfusion injury and recovery","volume":"173","author":"Deng","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0057","article-title":"Focus on echocardiography in hypertrophic cardiomyopathy\u2014Fourth in series. An article from the e-journal of the ESC Council for Cardiology Practice","volume":"13","author":"Peovska Mitevksa","year":"2015","journal-title":"E-J. Cardiol. Pract."},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0058","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/hrt.45.2.206","article-title":"Specificity of systolic anterior motion of anterior mitral leaflet for hypertrophic cardiomyopathy. Prevalence in a large population of patients with other cardiac diseases","volume":"45","author":"Maron","year":"1981","journal-title":"Br Heart J"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0059","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1016\/j.jacc.2006.07.065","article-title":"Noninvasive Cardiac Imaging in Patients with Hypertrophic Cardiomyopathy","volume":"48","author":"Nagueh","year":"2006","journal-title":"Am. Coll. Cardiol."},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0060","doi-asserted-by":"crossref","first-page":"1371286","DOI":"10.3389\/fped.2024.1371286","article-title":"Weight status change during four years and left ventricular hypertrophy in Chinese children","volume":"12","author":"Liu","year":"2024","journal-title":"Front Pediatr"},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103040_bib0061","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1186\/s12887-024-05216-w","article-title":"A case of pioneering subcutaneous implantable cardioverter defibrillator intervention in Timothy syndrome","volume":"24","author":"Zhang","year":"2024","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0063","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.athoracsur.2008.01.061","article-title":"Mitral Valve Abnormalities in Hypertrophic Cardiomyopathy: Echocardiographic Features and Surgical Outcomes","volume":"85","author":"Kaple","year":"2008","journal-title":"Ann Thorac Surg"},{"issue":"12","key":"10.1016\/j.cpcardiol.2025.103040_bib0064","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.1007\/s00277-024-06119-7","article-title":"Construction of AML prognostic model with CYP2E1 and GALNT12 biomarkers based on golgi- associated genes","volume":"103","author":"Bin","year":"2024","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0065","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jcmg.2008.09.002","article-title":"Echocardiography in Hypertrophic Cardiomyopathy","volume":"1","author":"Afonso","year":"2008","journal-title":"JACCC Cardiovasc. Imaging"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0066","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/ehjci\/jex323","article-title":"Cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy:The importance of clinical context","volume":"19","author":"Quarta","year":"2018","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0067","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1093\/eurheartj\/ehu154","article-title":"Significance of left ventricular apical\u2013basal muscle bundle identified by cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy","volume":"35","author":"Gruner","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0068","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12968-014-0066-0","article-title":"Prevalence of myocardial crypts in a large retrospective cohort study by cardiovascular magnetic resonance","volume":"16","author":"Child","year":"2014","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0069","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCIMAGING.112.972760","article-title":"Prevalence and Clinical Profile of Myocardial Crypts in Hypertrophic Cardiomyopathy","volume":"5","author":"Maron","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0070","unstructured":"Swoboda, P.P.; McDiarmid, A.K.; Erhayiem, B.; Broadbent, D.A.; Dobson, L.E.; Garg, P.; Ferguson, C."},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0071","article-title":"Assessing Myocardial Extracellular Volume by T1 Mapping to Distinguish Hypertrophic Cardiomyopathy from Athlete's Heart","volume":"67","author":"Page","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0072","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005311","article-title":"Lack of phenotypic differences by cardiovascular magnetic resonance imaging MYH7 (\u03b2-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-related hypertrophic cardiomyopathy","volume":"10","author":"Weissler-Snir","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.cpcardiol.2025.103040_bib100","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3390\/diagnostics12020489","article-title":"Anatomical-MRI correlations in adults and children with hypertrophic cardiomyopathy","volume":"12","author":"Rosu","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0073","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jacc.2009.05.006","article-title":"Hypertrophic Cardiomyopathy Phenotype Revisited After 50 Years with Cardiovascular Magnetic Resonance","volume":"54","author":"Maron","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0074","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12968-016-0308-4","article-title":"Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: A comprehensive review","volume":"18","author":"Haaf","year":"2016","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0075","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/CIRCIMAGING.112.000333","article-title":"T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy","volume":"6","author":"Ho","year":"2013","journal-title":"Circ. Cardiovasc.Imaging"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0076","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jcmg.2011.08.020","article-title":"CMR With Late Gadolinium Enhancement in Genotype Positive\u2013Phenotype Negative Hypertrophic Cardiomyopathy","volume":"5","author":"Rowin","year":"2012","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0077","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1161\/CIRCULATIONAHA.106.657023","article-title":"Evidence for Microvascular Dysfunction in Hypertrophic Cardiomyopathy","volume":"115","author":"Petersen","year":"2007","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.cpcardiol.2025.103040_bib0078","article-title":"Characteristics and outcomes of pediatric patients who undergo placement of implantable cardioverter defibrillators: insights from the National Cardiovascular Data Registry","volume":"11","author":"Baskar","year":"2018","journal-title":"Circulation: Arrhythmia and Electrophysiology"},{"issue":"9","key":"10.1016\/j.cpcardiol.2025.103040_bib0079","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jamacardio.2019.2861","article-title":"Development of a novel risk prediction model for sudden cardiac death in childhood hypertrophic cardiomyopathy (HCM Risk-Kids)","volume":"4","author":"Norrish","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"3","key":"10.1016\/j.cpcardiol.2025.103040_bib0080","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/CIRCULATIONAHA.120.047235","article-title":"A validated model for sudden cardiac death risk prediction in pediatric hypertrophic cardiomyopathy","volume":"142","author":"Miron","year":"2020","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.cpcardiol.2025.103040_bib0081","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1161\/CIRCULATIONAHA.122.062699","article-title":"The prevalence and association of exercise test abnormalities with sudden cardiac death and transplant-free survival in childhood hypertrophic cardiomyopathy","volume":"147","author":"Conway","year":"2023","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.cpcardiol.2025.103040_bib0082","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","article-title":"Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe)","volume":"138","author":"Ho","year":"2018","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.cpcardiol.2025.103040_bib0083","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/jamacardio.2018.0789","article-title":"Long-term outcomes of pediatric-onset hypertrophic cardiomyopathy and age-specific risk factors for lethal arrhythmic events","volume":"3","author":"Maurizi","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"11","key":"10.1016\/j.cpcardiol.2025.103040_bib0084","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1001\/jamaneurol.2015.1855","article-title":"A 22-year follow-up study of long-term cardiac outcome and predictors of survival in Friedreich ataxia","volume":"72","author":"Pousset","year":"2015","journal-title":"JAMA Neurol"},{"issue":"9908","key":"10.1016\/j.cpcardiol.2025.103040_bib0085","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/S0140-6736(13)61685-2","article-title":"Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: an analysis of data from the Pediatric Cardiomyopathy Registry","volume":"382","author":"Lipshultz","year":"2013","journal-title":"The Lancet"},{"issue":"5","key":"10.1016\/j.cpcardiol.2025.103040_bib0086","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/MOP.0000000000000669","article-title":"Cardiovascular disease in Noonan syndrome","volume":"30","author":"Pierpont","year":"2018","journal-title":"Curr Opin Pediatr"},{"issue":"3","key":"10.1016\/j.cpcardiol.2025.103040_bib0087","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/ejcts\/ezx369","article-title":"Clinical long-term outcome of septal myectomy for obstructive hypertrophic cardiomyopathy in infants","volume":"53","author":"Schleihauf","year":"2018","journal-title":"European Journal of Cardio-Thoracic Surgery"},{"issue":"4","key":"10.1016\/j.cpcardiol.2025.103040_bib101","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3390\/biom13040665","article-title":"Metalloproteinases and hypertrophic cardiomyopathy: a systematic review","volume":"13","author":"Serraino","year":"2023","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.cpcardiol.2025.103040_bib0088","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ahj.2012.04.018","article-title":"Outcomes in children with Noonan syndrome and hypertrophic cardiomyopathy: a study from the Pediatric Cardiomyopathy Registry","volume":"164","author":"Wilkinson","year":"2012","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.cpcardiol.2025.103040_bib0089","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1172\/JCI44929","article-title":"MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1 L613V mutation","volume":"121","author":"Wu","year":"2011","journal-title":"J clinical invest"},{"issue":"17","key":"10.1016\/j.cpcardiol.2025.103040_bib0090","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.jacc.2019.01.066","article-title":"Hypertrophic cardiomyopathy in Noonan syndrome treated by MEK-inhibition","volume":"73","author":"Andelfinger","year":"2019","journal-title":"J American College Cardiol"},{"issue":"11","key":"10.1016\/j.cpcardiol.2025.103040_bib0091","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1161\/CIRCULATIONAHA.119.044794","article-title":"Intronic CRISPR repair in a preclinical model of noonan syndrome\u2013associated cardiomyopathy","volume":"142","author":"Hanses","year":"2020","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.cpcardiol.2025.103040_bib0092","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1172\/JCI44972","article-title":"Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome\u2013associated PTPN11 mutation","volume":"121","author":"Marin","year":"2011","journal-title":"J clinical invest"},{"key":"10.1016\/j.cpcardiol.2025.103040_bib0093","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101466","article-title":"Clinical characteristics and survival of children with hypertrophic cardiomyopathy in China: a multicentre retrospective cohort study","volume":"49","author":"Chan","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"9646","key":"10.1016\/j.cpcardiol.2025.103040_bib0094","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","article-title":"Pompe's disease","volume":"372","author":"van der Ploeg","year":"2008","journal-title":"The lancet"},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103040_bib0095","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S2352-4642(21)00308-4","article-title":"Effect of alglucosidase alfa dosage on survival and walking ability in patients with classic infantile Pompe disease: a multicentre observational cohort study from the European Pompe Consortium","volume":"6","author":"Ditters","year":"2022","journal-title":"Lancet Child & Adolescent Health"},{"issue":"3","key":"10.1016\/j.cpcardiol.2025.103040_bib0096","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jacc.2009.03.051","article-title":"Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children","volume":"54","author":"Decker","year":"2009","journal-title":"J American College Cardiol"},{"issue":"36","key":"10.1016\/j.cpcardiol.2025.103040_bib0097","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280625000623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280625000623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T07:43:42Z","timestamp":1746085422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280625000623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":99,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0146280625000623"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2025.103040","relation":{},"ISSN":["0146-2806"],"issn-type":[{"type":"print","value":"0146-2806"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Multidimensional Approach to Understanding Genetic Diversity, Risk Stratification, and Personalized Interventions in Pediatric Hypertrophic Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2025.103040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103040"}}